Bixiye
Rapid to Intermediate Acting Insulin - Medicaid
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2025
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 271 - 280 ee natiijooyinka 3167
Bixiye
Long Acting Insulin - Commercial
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2025
Bixiye
Afrezza® - Medicaid
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2025
Bixiye
Long Acting Insulin - Medicaid
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2025
Bixiye
Interstitial Lung Disease (ILD) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2025
Bixiye
Multiple Sclerosis Agents - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2025
Bixiye
Multiple Sclerosis Agents - Commercial
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2025
Bixiye
Metformin ER - Commercial
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2025
Bixiye
Afrezza® (regular human insulin, inhaled) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2025
Bixiye
Topical Actinic Keratosis, Basal Cell Carcinoma, Genital Wart Agents - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2025